Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 30484-77-6
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Bag,Drum
Delivery Time: 7-15 days
Payment Terms: L/C, D/A, T/T, Western Union
Supply Ability: TON
CAS NO:: |
30484-77-6 |
Appearance:: |
White Crystalline Powder, Odorless And Tasteless |
Molecular Formula:: |
C26H28Cl2F2N2 |
Molecular Weight:: |
477.41700 |
EINECS NO:: |
250-216-6 |
MDL NO:: |
MFCD00058198 |
CAS NO:: |
30484-77-6 |
Appearance:: |
White Crystalline Powder, Odorless And Tasteless |
Molecular Formula:: |
C26H28Cl2F2N2 |
Molecular Weight:: |
477.41700 |
EINECS NO:: |
250-216-6 |
MDL NO:: |
MFCD00058198 |
Product Description:
Product Name: Flunarizine dihydrochloride CAS NO: 30484-77-6
Synonyms:
Flunarizine dihydrochloride,1-[Bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl)piperazine dihydrochloride;
Flunarizine-d8 dihydrochloride;
1-[Bis(4-fluorophenyl)Methyl]-4-[(2E)-3-phenyl-2-propen-1-yl]piperazine Hydrochloride;
Chemical & Physical Properties:
Appearance: White crystalline powder, odorless and tasteless
Assay :≥99.0%
Boiling Point: 511.3℃ at 760 mmHg
Melting Point: 204-210℃
Flash Point: 263℃
Storage Condition: 2-8℃
Safety Information:
RTECS: TK9187000
HS Code: 2933599090
WGK Germany: 3
Risk Statement: R22
Hazard Code: Xn
Signal Word: Warning
Hazard Declaration: H302
Symbol: GHS07
Calcium channel blocker; fluorinated derivative of Cinnarizine. Vasodilator (cerebral and peripheral). Flunarizine is a selective calcium entry blocker.Target: Calcium ChannelFlunarizine is a drug classified as a calcium channel blocker. Flunarizine is a non-selective calcium entry blocker with other actions including histamine H1 receptor blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy. It may help to reduce the severity and duration of attacks of paralysis associated with the more serious form of alternating hemiplegia, as well as being effective in rapid onset dystonia-parkinsonism (RDP). From Wikipedia.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.